These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 1762184

  • 1. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
    Nomura F, Ohnishi K, Ohto M, Takeda Y, Rikihisa T, Kanakubo Y.
    Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S, Sugiyama Y, Iga T, Hanano M, Sanjo K, Beppu T, Idezuki Y.
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [Abstract] [Full Text] [Related]

  • 3. Extraction of 125I-albumin microaggregates from portal blood. An index of functional portal blood supply in cirrhotics.
    Huet PM, Marleau D, Lavoie P, Viallet A.
    Gastroenterology; 1976 Jan; 70(1):74-81. PubMed ID: 1245287
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous measurement of effective hepatic blood flow and systemic circulation.
    Hashimoto M, Watanabe G.
    Hepatogastroenterology; 2000 Jan; 47(36):1669-74. PubMed ID: 11149029
    [Abstract] [Full Text] [Related]

  • 5. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
    Merkel C, Gatta A, Caregaro L, Sacerdoti D, Rondana M, Ruol A.
    Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
    [Abstract] [Full Text] [Related]

  • 6. Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis.
    Lay CS, Tsai YT, Kong CW, Lee FY, Lee SD, Chen KY, Chiang BN, Lo KJ.
    Hepatogastroenterology; 1988 Jun; 35(3):121-4. PubMed ID: 3402902
    [Abstract] [Full Text] [Related]

  • 7. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R, Padrini R, Perazzi M, De Martin S, Piccoli P, Palatini P.
    Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
    [Abstract] [Full Text] [Related]

  • 8. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model.
    Jiao LR, El-Desoky AA, Seifalian AM, Habib N, Davidson BR.
    Br J Surg; 2000 May; 87(5):568-74. PubMed ID: 10792311
    [Abstract] [Full Text] [Related]

  • 9. Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer.
    Ohnishi K.
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():6-10. PubMed ID: 2210613
    [Abstract] [Full Text] [Related]

  • 10. Comparison of quantitative methods to assess hepatic function: Pugh's classification, indocyanine green, antipyrine, and dextromethorphan.
    Figg WD, Dukes GE, Lesesne HR, Carson SW, Songer SS, Pritchard JF, Hermann DJ, Powell JR, Hak LJ.
    Pharmacotherapy; 1995 Jul; 15(6):693-700. PubMed ID: 8602375
    [Abstract] [Full Text] [Related]

  • 11. Verapamil pharmacokinetics and liver function in patients with cirrhosis.
    Finucci GF, Padrini R, Piovan D, Melica E, Merkel C, Gatta A, Zuin R.
    Int J Clin Pharmacol Res; 1988 Jul; 8(2):123-6. PubMed ID: 3378854
    [Abstract] [Full Text] [Related]

  • 12. Hepatic function and portal hemodynamics in patients with liver cirrhosis.
    Kawasaki T, Moriyasu F, Kimura T, Someda H, Tamada T, Yamashita Y, Ono S, Kajimura K, Hamato N, Okuma M.
    Am J Gastroenterol; 1990 Sep; 85(9):1160-4. PubMed ID: 2202201
    [Abstract] [Full Text] [Related]

  • 13. Hepatic parenchymal cell volume and the indocyanine green tolerance test.
    Hashimoto M, Watanabe G.
    J Surg Res; 2000 Aug; 92(2):222-7. PubMed ID: 10896825
    [Abstract] [Full Text] [Related]

  • 14. [Determination of hepatic blood flow in chronic liver diseases using the constant infusion technic].
    Vorobioff J, Carnovale C, Topol R, Picabea E, Villavicencio R, Tanno H, Audano M, Audano G.
    Acta Gastroenterol Latinoam; 1984 Aug; 14(3):229-34. PubMed ID: 6537116
    [Abstract] [Full Text] [Related]

  • 15. Sorbitol as a test substance for measurement of liver plasma flow in humans.
    Keiding S, Engsted E, Ott P.
    Hepatology; 1998 Jul; 28(1):50-6. PubMed ID: 9657096
    [Abstract] [Full Text] [Related]

  • 16. The abnormal hepatic scan of chronic liver disease: its relationship to hepatic hemodynamics and colloid extraction.
    Horisawa M, Goldstein G, Waxman A, Reynolds T.
    Gastroenterology; 1976 Aug; 71(2):210-3. PubMed ID: 939379
    [Abstract] [Full Text] [Related]

  • 17. [Hepatic blood flow, portal hypertension and liver failure in patients with alcoholic cirrhosis (author's transl)].
    Lebrec D, Sicot C, Benhamou JP.
    Arch Fr Mal App Dig; 1973 Sep; 62(6):465-71. PubMed ID: 4779228
    [No Abstract] [Full Text] [Related]

  • 18. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
    Hamberg O, Vilstrup H.
    Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
    [Abstract] [Full Text] [Related]

  • 19. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C, Brissot P, Messner M, Delamaire D, Gie S, Bourel M.
    Ann Gastroenterol Hepatol (Paris); 1984 Jan; 20(1):1-6. PubMed ID: 6529154
    [Abstract] [Full Text] [Related]

  • 20. Altered alanine plasma levels despite normalized hepatic alanine extraction in the long-term course after liver transplantation.
    Tietge UJ, Bahr MJ, Manns MP, Böker KH.
    Transplantation; 2003 Mar 27; 75(6):804-10. PubMed ID: 12660506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.